[Skip to Navigation]
Viewpoint
November 5, 2014

Addressing Prescription Opioid Overdose: Data Support a Comprehensive Policy Approach

Author Affiliations
  • 1Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland
  • 2Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
JAMA. 2014;312(17):1733-1734. doi:10.1001/jama.2014.13480

Preventing prescription opioid overdose deaths is a public health priority. Deaths from these medications exceed deaths from all illicit drugs combined.1 News reports, actions by states, and congressional legislation that single out the recently approved extended-release hydrocodone product Zohydro ER raise critical questions about the most effective policy needed to reverse the problem.

×